Latest News

Dr. Alex Jones, joins the Cytomos Board

07 September 2026
Cytomos has appointed life sciences executive Dr Alex Jones as a non-executive director as it moves to accelerate the commercialisation of its cell analysis technology.

Click to read more

BIO 2026 – Cytomos showcases groundbreaking new digital platform AuraCyt®, which enables earlier, smarter bioprocessing decisions

18 June 2026
22-25th June 2026: At this year’s annual meeting of the Bio International Convention (BIO) in San Diego, CA, TechBio company Cytomos (www.cytomos.com) is showcasing their flagship cell analytic intelligence platform AuraCyt® – together with its novel benchtop technology Celledonia® – which is set to revolutionise predictive cell analytics.
Click to read more

Cytomos Achieves ISO 9001 Certification with Zero Non-Conformances

12 August 2025
Cytomos is proud to announce that it has achieved ISO 9001:2015 certification with zero non-conformances identified during the external certification audit by BSI.
Click to read more

See the future of cell analysis and see beyond

To find out more about our revolutionary biotechnology, please click below and complete our form.